CD8A and neoplasm: The absence of CXCR3 seems not to interfere with the ex vivo-specific lysis against tumor cells (OT-I CD8 T cells/OVA-expressing tumor cells) nor with the IFNγ, TNFα or Granzyme B expression [11,81].